A comprehensive overview of key regulatory and quality requirements across gene therapy workflows

Fill out the form below to watch the webinar

In the face of a constantly evolving regulatory landscape, a firm grasp of cell and gene therapy manufacturing's requirements is becoming increasingly critical for developers. Without a thorough understanding, and robust, reproducible and compliant processes in place, roadblocks and rising costs can soon prove problematic.

In this webinar, Regulatory requirements for viral vector production platforms, speakers Scott Cross from Dark Horse Consulting Group, and Thermo Fisher's Shikha Mishra share their thoughts on regulatory compliance throughout the therapeutic development lifecycle and advise on best practices for producing high-quality viral vectors at scale.

You'll learn:

  • Key regulatory and quality requirements across gene therapy workflows, and the associated challenges faced by manufacturers today
  • Navigating the path from research and discovery to clinical and commercial manufacturing
  • Innovative and compliant solutions in viral vector manufacturing